Oliva, Dave L.
HRN: 00-30-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/08/2024
01/14/2024
IV
600mg
Q8
Pleural Effusion, Left; Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes